Clinical Trial Update: Supplemental Enteral Protein in Critical Illness [Phase 3]

View source ↗

Summary

Phase 3 trial results for supplemental enteral protein in critically ill patients have been posted after completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Nutrition Disorders
• Trauma

Drugs mentioned

• Enteral protein supplementation (protein supplement)

Snippet

Sponsor: University of Washington | Conditions: Nutrition Disorder, Trauma | Phase 3 | Status: COMPLETED | Results posted: 2024-06-05